A federal court tossed out an appeal on Tuesday from more than 25 hedge fund and investment firms worried of losing money to bigger Wall Street players after the 2008 downfall of Washington Mutual Bank.
An appeals court on Tuesday denied complaints from environmental groups that said federal regulators are ignoring the lessons from Japan’s Fukushima meltdown when approving the first U.S. nuclear construction project since 1978.
A federal court tossed out regulations that would require employers to post notices about union rights.
Attorney General Eric Holder has threatened litigation against Kansas over a new law that claims to nullify federal gun controls.
A federal court on Tuesday swatted down complaints from financial and tech giants who demanded a regulatory intervention by the Securities and Exchange Commission (SEC) on stock market fees.
Federal regulators acted fairly when denying drugmaker AstraZeneca an extension to the exclusive rights to make an antischizophrenic drug, an appeals court said Friday.
A court-ordered agreement between regulators and environmental groups to issue updated regulations on the waste runoff from power plants will go forward, a federal court said Tuesday.
The court rejected a request from the energy industry to overturn the consent order from 2010 that forced the Environmental Protection Agency (EPA) to use its powers under the Clean Water Act to review rules for power plant emissions.
The 2012 federal district court ruling essentially invalidates proposed
federal regulations limiting speculation on 28 commodities, including gasoline.
The settlement would allow Anheuser-Busch to purchase Grupo Modelo.
Amgen, based out of California, will pay the the settlement to resolve charges that it gave kickbacks to three long-term care pharmacy providers to implement a program designed to get Medicare and Medicaid beneficiaries to switch to Aranesp, a drug used to treat the blood disorder anemia.
The Department of Justice claims the company gave performance-based rebates to the pharmacy providers in exchange for getting people to switch to the drug.